Oxybutynin: Difference between revisions
{{Urologicals}} |
No edit summary |
||
| Line 21: | Line 21: | ||
Oxybutynin also shows promise for treatment of hyperhidrosis, or hyper-active sweating. |
Oxybutynin also shows promise for treatment of hyperhidrosis, or hyper-active sweating. |
||
As with all drugs, Oxybutynin is associated with a number of side effects (taken from the SPC for Ditropan www.medicines.org.uk) includes nausea, diarrhoea, constipation, dry mouth, abdominal discomfort, anorexia, vomiting, gastroesophageal reflux, agitation, headache, dizziness, drowsiness, disorientation, hallucinations, nightmares, convulsions, tachycardia, cardiac arrythmia, blurred vision, mydriasis, intraocular hypertension, onset of narrow-angle glaucoma, dry eyes, renal urinary retention, difficulty in micturition, facial flushing, dry skin, and allergic reactions such as rash, urticaria, angioedema and photosensitivity. |
|||
{{pharma-stub}} |
{{pharma-stub}} |
||
Revision as of 17:19, 21 August 2006
| File:Oxybutynin.png | |
| Clinical data | |
|---|---|
| ATC code | |
| Pharmacokinetic data | |
| Protein binding | 91%-93% |
| Elimination half-life | 12.4-13.2 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.158.590 |
| Chemical and physical data | |
| Formula | C22H31NO3 |
| Molar mass | 357.486 g/mol |
Oxybutynin is an anticholinergic medication used to relieve urinary and bladder difficulties, including frequent urination and inability to control urination (urge incontinence). It helps to decrease muscle spasms of the bladder. It antagonizes the muscarinic acetylcholine receptor. It is available orally in generic formulation and as the brand-names Ditropan® and Lyrinel XL®, and as a transdermal patch under the brand-name Oxytrol®.
Oxybutynin also shows promise for treatment of hyperhidrosis, or hyper-active sweating.
As with all drugs, Oxybutynin is associated with a number of side effects (taken from the SPC for Ditropan www.medicines.org.uk) includes nausea, diarrhoea, constipation, dry mouth, abdominal discomfort, anorexia, vomiting, gastroesophageal reflux, agitation, headache, dizziness, drowsiness, disorientation, hallucinations, nightmares, convulsions, tachycardia, cardiac arrythmia, blurred vision, mydriasis, intraocular hypertension, onset of narrow-angle glaucoma, dry eyes, renal urinary retention, difficulty in micturition, facial flushing, dry skin, and allergic reactions such as rash, urticaria, angioedema and photosensitivity.